Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects

Diabetes

Volumn 61, Issue 5, 2012, Pages 1210-1216

  Winhofer, Yvonne ^a   Krššák, Martin ^a   Janković, Draženka ^a   Anderwald, Christian Heinz ^a,b,c   Reiter, Gert ^d   Hofer, Astrid ^a   Trattnig, Siegfried ^a   Luger, Anton ^a   Krebs, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CNR   (Italy)

^c Specialized Hospital for Metabolic Diseases   (Austria)

^d SIEMENS AG ÖSTERREICH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; INSULIN; LIPID;

ADULT; ARTICLE; BODY MASS; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; MYOCARDIAL LIPID CONTENT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; LIPID METABOLISM; LIPIDS; MALE; MYOCARDIUM; YOUNG ADULT;

EID: 84860564387     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1275     Document Type: Article

References (37)

1. Rijzewijk LJ, van der Meer RW, Smit JW, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008;52:1793-1799
2. 1H-magnetic resonance spectroscopy study. Circulation 2007;116:1170-1175
3. Lingvay I, Raskin P, Szczepaniak LS. The fatty hearts of patients with diabetes. Nat Rev Cardiol 2009;6:268-269
4. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 2008;121:748-757
5. Stone PH, Muller JE, Hartwell T, et al.; The MILIS Study Group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989;14:49-57 (Pubitemid 19165535)
6. McGavock JM, Victor RG, Unger RH, Szczepaniak LS; American College of Physicians and the American Physiological Society. Adiposity of the heart, revisited. Ann Intern Med 2006;144:517-524 (Pubitemid 46780675)
7. Iozzo P, Lautamaki R, Borra R, et al. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 2009;94:4472-4482
8. Krssak M, Falk Petersen K, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-116 (Pubitemid 29039748)
9. Krssak M, Roden M. The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans. Rev Endocr Metab Disord 2004;5:127-134 (Pubitemid 39012110)
10. Krebs M, Roden M. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab 2005;7:621-632 (Pubitemid 41601067)
11. Krssak M, Winhofer Y, Gobl C, et al. Insulin resistance is not associated with myocardial steatosis in women. Diabetologia 2011;54:1871-1878
12. Hammer S, Jonker JT, Lamb HJ, et al. Short-term hyperglycemic dysregulation in patients with type 1 diabetes does not change myocardial triglyceride content or myocardial function. Diabetes Care 2008;31:1613-1614
13. Bilet L, van de Weijer T, Hesselink MK, et al. Exercise-induced modulation of cardiac lipid content in healthy lean young men. Basic Res Cardiol 2011; 106:307-315
14. Hammer S, van der Meer RW, Lamb HJ, et al. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 2008; 93:497-503 (Pubitemid 351240822)
15. Hammer S, van der Meer RW, Lamb HJ, et al. Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2008;295:E714-E718
16. van der Meer RW, Hammer S, Lamb HJ, et al. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab 2008;93:2702-2708 (Pubitemid 352008539)
17. Anderwald C, Bernroider E, Krssak M, et al. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 2002;51:3025-3032
18. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789
19. Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009;297:E578-E591
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223 (Pubitemid 9249478)
21. van der Meer RW, Doornbos J, Kozerke S, et al. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 2007;245:251-257 (Pubitemid 47417809)
22. 1H MRS at 3 Tesla. Magn Reson Med 2011;66:619-624
23. 1H NMR relaxation times of skeletal muscle metabolites at 3 T. MAGMA 2004;16:155-159
24. Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69
25. Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 2005;289:E935-E939 (Pubitemid 41504396)
26. Velagaleti RS, Gona P, Chuang ML, et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging 2010;3:257-263
27. Waiter GD, McKiddie FI, Redpath TW, Semple SI, Trent RJ. Determination of normal regional left ventricular function from cine-MR images using a semi-automated edge detection method. Magn Reson Imaging 1999;17: 99-107 (Pubitemid 29036109)
28. van der Meer RW, Diamant M, Westenberg JJ, et al. Magnetic resonance assessment of aortic pulse wave velocity, aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus. J Cardiovasc Magn Reson 2007;9:645-651 (Pubitemid 46956896)
29. Dyck DJ, Steinberg G, Bonen A. Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab 2001;281:E600-E607
30. Schwenk RW, Luiken JJ, Bonen A, Glatz JF. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res 2008;79:249-258 (Pubitemid 351951617)
31. Witters LA, Kemp BE. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 59-AMP-activated protein kinase. J Biol Chem 1992;267:2864-2867
32. Peterson LR, Saeed IM, McGill JB, et al. Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans. Obesity (Silver Spring). 4 August 2011 [Epub ahead of print]
33. Klein LJ, van Campen CM, Sieswerda GT, Kamp O, Visser FC. Effects of high-dose insulin infusion on left ventricular function in normal subjects. Neth Heart J 2010;18:183-189
34. Tack CJ, Lenders JW, Goldstein DS, Lutterman JA, Smits P, Thien T. Haemodynamic actions of insulin. Curr Opin Nephrol Hypertens 1998;7: 99-106 (Pubitemid 28037528)
35. Harmancey R, Wilson CR, Wright NR, Taegtmeyer H. Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis. J Lipid Res 2010;51:1380-1393
36. Taegtmeyer H, Stanley WC. Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotection. J Mol Cell Cardiol 2011;50: 2-5
37. Johnson NA, Walton DW, Sachinwalla T, et al. Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology 2008;47:1513-1523 (Pubitemid 351702735)